These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12450706)

  • 1. Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly.
    Fry AM; Zell ER; Schuchat A; Butler JC; Whitney CG
    Vaccine; 2002 Dec; 21(3-4):303-11. PubMed ID: 12450706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pneumococcal polysaccharide vaccine on nonbacteremic pneumococcal pneumonia.
    Weiser JN; Austrian R
    Clin Infect Dis; 2007 Apr; 44(8):1139-40; author reply 1140-1. PubMed ID: 17366469
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
    Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
    Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in pneumococcal vaccines: what are the advantages for the elderly?
    Vila-Córcoles A
    Drugs Aging; 2007; 24(10):791-800. PubMed ID: 17896829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease.
    Molrine DC; George S; Tarbell N; Mauch P; Diller L; Neuberg D; Shamberger RC; Anderson EL; Phillips NR; Kinsella K; Ambrosino DM
    Ann Intern Med; 1995 Dec; 123(11):828-34. PubMed ID: 7486464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new pneumococcal vaccine.
    Obaro SK
    Clin Microbiol Infect; 2002 Oct; 8(10):623-33. PubMed ID: 12390280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pneumococcal surface protein A and new approaches for pneumococcal vaccine development].
    Vorob'ev DS; Semenova IB
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):107-13. PubMed ID: 22308742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.
    Schaballie H; Wuyts G; Dillaerts D; Frans G; Moens L; Proesmans M; Vermeulen F; De Boeck K; Meyts I; Bossuyt X
    Clin Exp Immunol; 2016 Aug; 185(2):180-9. PubMed ID: 26939935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of pneumococcal polysaccharide vaccines: no simple answers.
    French N
    J Infect; 2003 Feb; 46(2):78-86. PubMed ID: 12634068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
    Dagan R; Kayhty H; Wuorimaa T; Yaich M; Bailleux F; Zamir O; Eskola J
    Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal disease in the elderly: what is preventing vaccine efficacy?
    Rubins JB; Janoff EN
    Drugs Aging; 2001; 18(5):305-11. PubMed ID: 11392439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
    Kothari N; Kothari S; Choi YJ; Dey A; Briles DE; Rhee DK; Carbis R
    Vaccine; 2015 Feb; 33(6):783-8. PubMed ID: 25545593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal vaccination of older adults: conjugate or polysaccharide?
    Fedson DS; Guppy MJ
    Hum Vaccin Immunother; 2013 Jun; 9(6):1382-4. PubMed ID: 23732892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
    Lin H; Peng Y; Lin Z; Zhang S; Guo Y
    Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine.
    Herbert JA; Kay EJ; Faustini SE; Richter A; Abouelhadid S; Cuccui J; Wren B; Mitchell TJ
    Vaccine; 2018 Jun; 36(26):3809-3819. PubMed ID: 29778517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possibility of application of new pneumococcal conjugate vaccines in children in Slovenia.
    Paragi M; Kolman J; Kraigher A; Cizman M; Gubina M; Ribic H;
    Vaccine; 2003 Dec; 21(32):4708-14. PubMed ID: 14585680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia.
    Sherwin RL; Gray S; Alexander R; McGovern PC; Graepel J; Pride MW; Purdy J; Paradiso P; File TM
    J Infect Dis; 2013 Dec; 208(11):1813-20. PubMed ID: 24092845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal conjugate vaccines. A review.
    Galiza EP; Heath PT
    Minerva Med; 2007 Apr; 98(2):131-43. PubMed ID: 17519855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.